Perrigo Company
PRGO
|
$30.49
1.43%
0.0%
1.1M
|
Health Technology
(0.0% 1d) (-1.7% 1m) (-15.8% 1y) (0.0% 2d) (1.4% 3d) (-1.0% 7d) (-21.39% volume)
Earnings Calendar:
Market Cap: $ 4,131,880,980
http://www.perrigo.com
Sec Filling | Patents | 11200 employees
(IE) Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
israel brands diagnostics
Drugs
ESTRADIOL VALERATE (ESTRADIOL VALERATE)add to watch list Paper trade email alert is off
Press-releases
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.13%
H: 1.89%
C: 1.3%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
fda bladder cancer treatment
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.4%
H: 3.01%
C: 2.94%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -1.06%
H: 0.21%
C: -1.05%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
drug label astrazeneca expansion for kids
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
Global Immune Health Supplements Outlook Report 2023-2029: Vendors Focus on Advancements and Quality, Creating Competition by Offering Innovative Solutions
Published: 2024-03-29 (Crawled : 11:00) - prnewswire.com
BRBR | $56.17 1.98% 0.0% 830K
|
Health Technology
| Email alert
Add to watchlist
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
MEDE | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
report health offering global solutions
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
fda hepatitis kidney anemia
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.84%
H: 1.48%
C: 1.29%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
fda rare
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10